This Solicitation opportunity from Department Of Defense was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DIBUCAINE OINTMENT

Closed

SPE2DP-26-T-3402Federal

Submission Closed05/20/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Non-Substitutable Pharmaceutical IngredientsThis contract involves the supply of proprietary, branded pharmaceutical components including TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®, which are essential ingredients used in Total Parenteral Nutrition (TPN) formulations. The contract emphasizes full traceability and compliance with regulatory standards to ensure the safety and quality of these non-substitutable pharmaceutical ingredients. The procurement is managed by the Defense Health Agency Hcd West under the Department of Defense, reflecting the critical nature of these supplies for health services within defense operations. The solicitation was posted on June 15, 2026, with a response deadline set for June 30, 2026. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The place of performance falls within the 98431 zip code area, though specific city or state details are not disclosed. This contract supports the continued availability of specialized pharmaceutical components necessary for patient nutrition and care in military healthcare settings.

Defense Health Agency Hcd West

POSTED

DEADLINE

Custom Sterile Compounding of Total Parenteral Nutrition (TPN) FormulationsThe contract involves the manufacture and delivery of patient-specific, sterile Total Parenteral Nutrition (TPN) formulations, including branded products such as TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®. These formulations must be provided in volumes ranging from 1000 to over 3000 mL, with an absolute requirement for zero tolerance for deviations, ensuring strict adherence to quality and safety standards. This precision is critical given the nature of the products and their use in patient care. Administered by the Defense Health Agency Hcd West under the Department of Defense, the contract is categorized under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract is structured as a subcontract with a deadline for responses set for June 30, 2026. Performance is designated for an area identified by the zip code 98431. The contract underscores the importance of reliable, high-quality sterile compounding to meet defense health requirements with strict compliance to specifications and timelines.

Defense Health Agency Hcd West

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

5 days ago

DEADLINE

in 27 days

AI Contract Overview

This contract outlines the procurement of DIBUCAINE OINTMENT, USP, specifically a 1 percent ointment supplied in one-ounce (28 grams) collapsible tubes with rectal applicators, intended for rectal administration and external use only. The ointment must meet strict quality and packaging standards, including a minimum remaining shelf life of 31 months upon receipt and a total shelf life of 36 months stored between 15-30 degrees Celsius. Packaging must adhere to commercial standards while protecting the product during transit, comply with Medical Marking Standard No. 1, and include specific labeling elements such as National Stock Number, manufacturer information, manufacture and expiration dates, contract number, and lot number. The product is FDA regulated and must meet Department of Defense requirements referenced in detailed technical and quality documents. The contract calls for a quantity of five packages, with delivery required within 20 days, to be shipped FOB destination to a specified military postal address. Packaging and shipping must comply with relevant DLA and ASTM standards and all markings in accordance with applicable military standards to ensure safe and low-cost delivery. The solicitation is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, designated under NAICS code 325412, with the primary point of contact provided. The contract stresses the importance of adhering to current revisions of DLA master technical requirements throughout the acquisition process, ensuring product quality, compliance, and traceability.

General Info

Procure five 1% Dibucaine ointment packages meeting FDA, DoD, and packaging standards, delivered FOB.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

UNIT 100494 BOX 1, FPO, AP, 96678, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3402.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 14

Solicitation

Response DeadlineMay 20

Deadline has passed

Submission Closed

05/20/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

Alec Deichman

contact@example.gov

+1 (555) 000-0000

Full Description

DIBUCAINE OINTMENT
DIBUCAINE OINTMENT,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
CONTAINS 1 PERCENT OF DIBUCAINE OINTMENT
AS THE ACTIVE INGREDIENT
.
COMES SUPPLIED IN A COLLAPSIBLE TUBE
AND RECTAL APPLICATOR
.
RECTALLY ADMINISTERED
.
FOR EXTERNAL USE ONLY
.
UNIT OF ISSUE IS A PACKAGE CONTAINING
ONE (1) OUNCE OR 28 GRAMS
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT
BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 15-30 DEGREES CELSIUS OR
59 TO 86 DEGREES FARENHEIT
.
LABELING AND MARKING:
MUST INCLUDE THE FOLLOWING:
NATIONAL STOCK NUMBER,
MANUFACTURER,
DATE OF MANUFACTURER,
EXPIRATION DATE OR RETEST DATE,
CONTRACT NUMBER
AND LOT NUMBER
.
1/7/2015
1 PG = 28 GM
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
SPE2DP-26-T-3402
SECTION B
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00536-1211-95
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016779194 0001 PG 5.000
NSN/MATERIAL:6505002999535
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
SPE2DP-26-T-3402
SECTION B
PR: 7016779194 PRLI: 0001 CONT’D
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
UNIT 100494 BOX 1
FPO AP 96678
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
N23193
USNS ALAN SHEPARD T AKE 3
DLA VENDORS: USE VSM FOR
US
M/F: (TCN) N231936133S283
RDD: 777
PROJ: HJ5 TP 2
SUPP ADD: YPHARM SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: E5
Need Ship Date:00/00/0000 Original Required Delivery Date:05/18/2026
SPE2DP-26-T-3402 NSN/Part Number: 6505-00-299-9535 Quantity: 5 PG Purchase Request: 7016779194QTY: 5 Delivery: 20 days ADO